Partnership for Safe Medicines India
Formed: Decemer 2010
Website: www.safemedicinesindia.in
Media contact (India): Toll Free Helpline:1800-11-4424
Media contact (US): Teresa Schofield, teresa@safemedicines.org, +1.202.347.7947
Media fact sheet: About PSM India [PDF]
Media coverage:
- Partnership For Safe Medicines Launches India Initiative,
The Business Standard - Health Group to Protect Consumers Against Fake Drugs,
Press Trust of India - Partnership for Safe Medicines begins India Initiative,
Indian Express - Consumers Get Anti-Fake Drugs Watchdog,
The Financial Express - Health Group to Protect Consumers Against Fake Drugs,
The Wall Street Journal - Partnership for Safe Medicines Starts India Initiative,
The India Report - Partnership for Safe Medicines (PSM) Announces Major International Expansion with Launch of (PSM) India, Media Info World
- Stakeholders Join Together to Launch Partnership for Safe Medicines to Fight Spurious Drugs, Pharmabiz.com
- In Turnabout, India to Send Inspectors Overseas, Fierce Pharma
- Partnership For Safe Medicines (PSM) Announces Major International Expansion with Launch of India Initiative, Healthcare Packaging
- PSM Forms Affiliate to Tackle Counterfeits in India, In-Pharma Technologist
- Partnership for Safe Medicines launches Indian Initiative, Securing Pharma
- Global Group Against Fake Drugs PSM Launches India Unit, Trading Markets
- US Drug Agency seeks CBI help for Counterfeit Info, The Financial Express
- Mumbai Sandhya, print only
- Mumbai Mitra, print only
Mission: To serve as a coalition of organizations and individuals seeking to protect consumers from spurious or contraband medicines in the country.
- To raise public awareness of the harms to patient safely caused by spurious drugs
- To inform consumers and distributors of medicines in the community the existence and extent of spurious drug problem
- To work collaboratively with the medical community
- To educate Indian consumers on the importance of drug quality, how to identify suspected spurious drugs, and what actions to take when encounter a suspected case
- To educate community healthcare practitioners in drugstores and health centers on the problem of spurious drugs and what role they can play to lessen the problem
Initial core group members:
- Mr Ashok Kumar, 47, New Moti Bagh, New Delhi-110023
- Dr. Meera Mitra, Governing Council Member, Cell for Consumer Education and Advocacy, Greater Kailash Enclave I, New Delhi 110048
- Ms. Reena George, Cankids, Sector 14, Noida
- Dr Manisha K Bhatla, Escorts Heart Institute & Research Centre, Okhla Road, New Delhi – 110 025
- Dr. Prafull D. Sheth, Vice President, International Pharmaceutical Federation, E-256, Greater Kailash I, New Delhi -110048
- Mr Bejon Misra, Founder Trustee, Consumer Online Foundation, D-14, 1st Floor, Greater Kailash Enclave II, New Delhi – 110 048
- Mr. S., Krishnan, Chairman, Healthy You Foundation, E-212, Anand Lok, Mayur Vihar-I, Delhi – 110 091
- Mr. Brijesh Regal, Chief Executive Officer, Apothecaries Clinical Research, 579, Devli, East Sainik Farms, New Delhi – 110 062
- Dr. Vinay Agarwal, President Elect, Indian Medical Association, IMA House, Indraprastha Marg, New Delhi – 110 002
- Ms. Vandana Saxena, Vice President, Consumers’ Forum, 228, Sidhartha Enclave, New Delhi – 110 014
- Mr. A. K Jain, Principal Advisor, Quality Council of India, 2ndfloor, Institution of Engineers Building, Bahadurshah Zafar Marg, New Delhi – 110 002
- Dr Rashmi Kulshrestha, Regulatory Consultant, Regulatory Wisdom, 113-114, Vardhman Grand Market, Sector 3, Dwarka, New Delhi – 110 078
- Dr Raja Smarta, Managing Director, Interlink Marketing Consultancy Pvt.Ltd., 3A, Central Plaza, 166 CST Road, Kalina, Santacruz (East), Mumbai – 400 098
- Mr. T. K. Govindan, A/62 Double Storey, Kalkaji Main Road, New Delhi 110019.
